The role of cyclooxygenases in inflammation, cancer, and development

The cyclooxygenase (COX) enzymes catalyze a key step in the conversion of arachidonate to PGH2, the immediate substrate for a series of cell specific prostaglandin and thromboxane synthases. Prostaglandins play critical roles in numerous biologic processes, including the regulation of immune function, kidney development, reproductive biology, and gastrointestinal integrity. There are two COX isoforms, which differ mainly in their pattern of expression. COX-1 is expressed in most tissues, whereas COX-2 usually is absent, but is induced by numerous physiologic stimuli. Surprisingly, disruption of Cox1 (Ptgs1) in the mouse did not result in gastrointestinal abnormalities. cox-2 (Ptgs2) null mice show reproductive anomalies and defects in kidney development. Epidemiologic, animal, and human data indicate that NSAIDs, inhibitors of cyclooxygenase, are chemopreventive for colon cancer. COX-2 is overexpressed in 50% of benign polyps and 80 – 85% of adenocarcinomas. Offspring from cox-2 null by ApcΔ716 matings exhibit an 86% reduction in polyp number when compared to offspring from control animals, thus providing genetic evidence that COX-2 contributes to tumor formation or growth. The in vivo mechanism by which COX-2 affects tumor growth has not been determined. It is possible that both tumor and stromally derived COX-2 could influence tumor angiogenesis and/or immune function.

[1]  D. McCarthy,et al.  Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. , 1991, Annals of internal medicine.

[2]  L. Spain,et al.  Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development. , 1999, The Journal of clinical investigation.

[3]  S. Dey,et al.  Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice , 1997, Cell.

[4]  L. Marnett,et al.  Aspirin-like molecules that covalently inactivate cyclooxygenase-2. , 1998, Science.

[5]  K. Kinzler,et al.  Landscaping the Cancer Terrain , 1998, Science.

[6]  C. Williams,et al.  Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.

[7]  D. Coyne,et al.  Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids. , 1992, The American journal of physiology.

[8]  J. Morrow,et al.  The catalytic outcomes of the constitutive and the mitogen inducible isoforms of prostaglandin H2 synthase are markedly affected by glutathione and glutathione peroxidase(s). , 1995, Biochemistry.

[9]  S. Gabriel,et al.  Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. , 1991, Annals of internal medicine.

[10]  M. Washington,et al.  Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. , 1999, Carcinogenesis.

[11]  L. Matrisian,et al.  Differential expression of matrilysin and cyclooxygenase‐2 in intestinal and colorectal neoplasms , 1999, Molecular carcinogenesis.

[12]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[13]  C. McCall,et al.  Lipopolysaccharide induces prostaglandin H synthase-2 in alveolar macrophages. , 1992, Biochemical and biophysical research communications.

[14]  M. Thun,et al.  Aspirin use and risk of fatal cancer. , 1993, Cancer research.

[15]  S K Das,et al.  Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. , 1996, Journal of molecular endocrinology.

[16]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[17]  V. Hial,et al.  Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse. , 1976, European journal of pharmacology.

[18]  C. Torrance,et al.  Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.

[19]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[20]  R. DuBois,et al.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. , 1996, Gastroenterology.

[21]  L. Wennogle,et al.  Comparison of recombinant cyclooxygenase‐2 to native isoforms: aspirin labeling of the active site , 1995, FEBS letters.

[22]  S. Piantadosi,et al.  Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.

[23]  V. Steele,et al.  Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. , 1997, Cancer research.

[24]  D. Levy,et al.  Identification of a phorbol ester-repressible v-src-inducible gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Riendeau,et al.  Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. , 1996, Gastroenterology.

[26]  Bandaru S. Reddy,et al.  Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. , 1997, Cancer research.

[27]  J. Johnston,et al.  Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II , 1995, Nature.

[28]  P. Mukherjee,et al.  Platelet-activating factor and retinoic acid synergistically activate the inducible prostaglandin synthase gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. DuBois,et al.  Elevated cyclooxygenase-2 levels in Min mouse adenomas. , 1996, Gastroenterology.

[30]  P. Netzer,et al.  Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats , 1998, British journal of pharmacology.

[31]  M. Memo,et al.  Neuroprotection by Aspirin and Sodium Salicylate Through Blockade of NF-κB Activation , 1996, Science.

[32]  T. Miller.  Protective effects of prostaglandins against gastric mucosal damage: current knowledge and proposed mechanisms. , 1983, The American journal of physiology.

[33]  T. Zakar,et al.  Prostaglandin endoperoxide-H synthase-1 and -2 messenger ribonucleic acid levels in human amnion with spontaneous labor onset. , 1995, The Journal of clinical endocrinology and metabolism.

[34]  M. Kasuga,et al.  Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. , 1997, Gastroenterology.

[35]  J. Falgueyret,et al.  Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitor , 1997, British journal of pharmacology.

[36]  R. Coffey,et al.  Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. , 1994, Gastroenterology.

[37]  P. Vielh,et al.  Sulindac causes regression of rectal polyps in familial adenomatous polyposis. , 1991, Gastroenterology.

[38]  M. Pollard,et al.  Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. , 1981, Science.

[39]  W. Boyar,et al.  Analysis of hydroperoxide-induced tyrosyl radicals and lipoxygenase activity in aspirin-treated human prostaglandin H synthase-2. , 1997, Biochemistry.

[40]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[41]  M. Oka,et al.  Prostaglandin E2 levels and lymphocyte subsets in portal venous drainage of colorectal cancers. , 1994, American journal of surgery.

[42]  J. Vane,et al.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. , 1971, Nature: New biology.

[43]  M. Thun,et al.  Aspirin use and reduced risk of fatal colon cancer. , 1991, The New England journal of medicine.

[44]  R. Hardman,et al.  Phorbol ester and epidermal growth factor enhance the expression of two inducible prostaglandin H synthase genes in rat tracheal epithelial cells. , 1993, Archives of Biochemistry and Biophysics.

[45]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[46]  R. Copeland,et al.  Mechanism of selective inhibition of the inducible isoform of prostaglandin G/H synthase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Morrow,et al.  Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. , 1997, The Journal of clinical investigation.

[48]  M. Mattei,et al.  Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[49]  G. Thomas,et al.  Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2. , 1994, Gut.

[50]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[51]  J. Morrow,et al.  Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. , 1994, The Journal of clinical investigation.

[52]  M. Mcentee,et al.  Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis. , 1997, Cancer research.

[53]  D. Dewitt,et al.  Serum and glucocorticoid regulation of gene transcription and expression of the prostaglandin H synthase-1 and prostaglandin H synthase-2 isozymes. , 1993, Archives of biochemistry and biophysics.

[54]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[55]  H. Jacobson,et al.  Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. , 1994, The Journal of clinical investigation.

[56]  J. Morrow,et al.  Meloxicam inhibits the growth of colorectal cancer cells. , 1998, Carcinogenesis.

[57]  V. Steele,et al.  Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents. , 1994, Carcinogenesis.

[58]  S Jothy,et al.  Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.

[59]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[60]  J. Morrow,et al.  Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. , 1999, Genes & development.

[61]  J. Morrow,et al.  Sulindac sulfide, but not sulindac sulfone, inhibits colorectal cancer growth. , 1999, Neoplasia.

[62]  K. Resch,et al.  Transient expression of prostaglandin endoperoxide synthase‐2 during mouse macrophage activation , 1994, Journal of leukocyte biology.

[63]  C. Bonifer,et al.  © 1999 Cancer Research Campaign Article no. bjoc.1998.0224 Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice , 2022 .

[64]  R. Gaynor,et al.  Sulindac Inhibits Activation of the NF-κB Pathway* , 1999, The Journal of Biological Chemistry.

[65]  R. White,et al.  Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Schafer.  Effects of Nonsteroidal Antiinflammatory Drugs on Platelet Function and Systemic Hemostasis , 1995, Journal of clinical pharmacology.

[67]  J. Lehmann,et al.  Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs* , 1997, The Journal of Biological Chemistry.